Postoperative pancreatic fistula after gastrectomy for gastric cancer
- PMID: 33319151
- PMCID: PMC7726690
- DOI: 10.1002/ags3.12398
Postoperative pancreatic fistula after gastrectomy for gastric cancer
Abstract
Postoperative pancreatic fistula is one of the most severe complications after gastric cancer surgery, and can cause critical patient conditions leading to surgery-related death. Fortunately, the incidence of postoperative pancreatic fistula after gastrectomy seems to be decreasing with changes in operative procedures. The rate was reported at about 30% after open gastrectomy with Appleby's method in 1997, but lately has improved below 1% for robotic gastrectomy in 2019. For the diagnosis of postoperative pancreatic fistula, drain amylase concentration has been demonstrated to be beneficial and some reports have proposed the optimal cut-off values of drain amylase to predict major postoperative pancreatic fistula. There have been many reports identifying risk factors for postoperative pancreatic fistula, including overweight patients, pancreatic anatomy, blunt trauma from compression of the pancreas, and thermal injuries caused by the continuous use of energy devices. And importantly, laparoscopic gastrectomy has been shown to be more often associated with postoperative pancreatic fistula than open gastrectomy in the prospective national clinical database in Japan. Hence, further sophistication of surgical techniques to reduce pancreas compression would have great promise in reducing postoperative pancreatic fistula after laparoscopic gastrectomy.
Keywords: gastrectomy; gastric cancer; pancreatic fistula.
© 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology.
Conflict of interest statement
Conflict of Interest: Authors declare no conflicts of interest for this article.
Figures



References
-
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53. - PubMed
-
- Wu C‐W, Hsiung CA, Lo S‐S, Hsieh M‐C, Chen J‐H, Li A‐Y, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309–15. - PubMed
-
- Bonenkamp JJ, Songun I, Welvaart K, van de Velde C, Hermans J, Sasako M, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745–8. - PubMed
-
- Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15‐year follow‐up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49. - PubMed
-
- Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy‐assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994;4:146–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical